INTRODUCTION
Neuroimmune interactions arise from at least two types of pathways (Felten, 2000; Sternberg, 2006; Thayer and Sternberg, 2010; Watkins and Maier, 1999) : neurohormonal pathways that depend on circulating hormones such as cortisol and catecholamines including norepinephrine, and neural pathways that are mainly mediated by direct neural connections with lymphoid organs like the thymus, bone marrow, spleen, and lymph nodes. Detailed anatomical analysis has suggested the lymphoid organs are innervated by the peripheral nervous system (Sternberg, 2006) , the sympathetic nervous system (Nance and Sanders, 2007) , and the parasympathetic nervous system (Tracey, 2007) . Thus, neurohormonal pathways likely regulate immune responses systemically, while neural pathways regulate immune responses at a local and regional level, resulting in regional property differences even within the same organ. Although the systemic effects of neurohormonal pathways have been well investigated, little is known about the mechanisms used by the local neural pathways.
The central nervous system (CNS) is an immune-privileged environment, protected by the blood-brain barrier, which is formed by specific vessels tightly attached to each other (Galea et al., 2007; Wilson et al., 2010) . This barrier, however, can be compromised upon the invasion of certain pathogens and/or latent infections (McGavern and Kang, 2011; Salinas et al., 2010) , suggesting that immune cells in the peripheral lymphoid organs contribute to CNS related immune responses. However, how these cells enter and/or accumulate in the CNS from peripheral lymphoid organs is unclear. Moreover, although pathogenic CD4+ T cells, which express high levels of cytokines such as IL-17A and IFNg and include autoreactive cells in peripheral lymphoid organs, are believed to play an essential role in the pathogenesis of MHC class II-associated autoimmune diseases like multiple sclerosis (MS) (Reboldi et al., 2009; Wilson et al., 2010) , the initial gates of entry through the blood-brain barrier have yet to be analyzed, particularly at the molecular level. It is known that leukocytes like CD4+ T cells migrate into the CNS through the choroid plexus and subarachnoid space, brain regions that show excess chemokine levels, including the CCL20 chemokine, specifically in late phases of disease development, suggesting that pathogenic CD4+ T cells can migrate from the blood directly into the brain tissues during these phases (Ransohoff, 2009; Reboldi et al., 2009; Wilson et al., 2010) . Further, it has been hypothesized that barrier properties and/or the vasculature itself differ between CNS compartments and that these differences may influence immune cell access (Wilson et al., 2010) . We hypothesize that these differences may arise from regional neural activation around the vessels, such that regional neural activation can regulate immune cell/blood cell accumulation in the CNS.
An important mediator for this regulation may be the NFkBtriggered positive-feedback-loop for IL-6 expression (IL-6 amplifier) in endothelial cells, which line blood and lymphatic vessels. We previously showed that this feedback loop is a synergistic activator of NFkB and STAT3 in type 1 collagen+ cells after IL-17A and IL-6 stimulation. Activation of the IL-6 amplifier can lead to excess expression of various chemokines and cytokines including CCL20 and IL-6 and the development of autoimmune diseases like F759 arthritis and experimental autoimmune encephalomyelitis (EAE), which is a multiple sclerosis model induced by a myelin oligodendrocyte glycoprotein (MOG)-derived autopeptide immunization (Hirano, 2010; Ogura et al., 2008) . Additionally, those reports found that IL-6 amplifier activation in mouse joints directly or indirectly causes accumulation of various immune cell/blood cell populations including IL-17A-and IFNg-expressing pathogenic CD4+ T cells there. Knowing this, we examined whether endothelial cell stimulation that depends on neural activity can trigger the IL-6 amplifier to cause regional pathogenic CD4+ T cell migration into the CNS. We demonstrate that regional neural activation defines a gateway for autoreactive T cells to cross the bloodbrain barrier via the IL-6 amplifier activation in endothelial cells at the fifth lumbar cord.
RESULTS

Transfused Pathogenic CD4+ T Cells Mainly Migrate to the CNS via the Fifth Lumbar Cord during the Early Stages of Autoimmune Disease Development
To discover the gates of entry into the CNS for immune cells including pathogenic CD4+ T cells, we employed a passive transfer method for EAE induction as described previously (Ogura et al., 2008) . Pathogenic CD4+ T cells were isolated from wild-type C57BL/6 mice immunized with a MOG peptide plus adjuvants (see the Experimental Procedures) and then cultured in vitro with bone marrow-derived dendritic cells in the presence of the same MOG peptide plus IL-23. The resulting pathogenic CD4+ T cells contained Th1 and Th17 cells and were intravenously transferred into wild-type C57BL/6 mice. EAE development peaked at about 10-12 days after the transfer (Figure S1A available online).
It has been reported pathogenic CD4+ T cells accumulate in the choroid plexus from day 13 after EAE induction by systemic immunizations in C57BL/6 mice (Reboldi et al., 2009 ). We found no T cell accumulation around the choroid plexus during the first 5 days after pathogenic CD4+ T cell transfer in untreated mice (data not shown). Because we have observed that pathogenic T cells mainly accumulate in the spinal cord around day 10 of EAE development (Sawa et al., 2009) , we hypothesized that pathogenic CD4+ T cells do not directly migrate to the choroid plexus, but may accumulate in the spinal cord instead, making the spinal cord a candidate for the gate in our model. We therefore investigated CD4+ T cell numbers in the spinal cord over first 5 days. We first investigated pathogenic CD4+ T cell accumulation in the CNS by using anterior-posterior whole mount sections after the transfer, finding robust pathogenic CD4+ T cell accumulation in the lumbar level, but not in the thoracic and cervical levels of the spinal cord (data not shown). We then analyzed the lumbar level in detail. Because more than 95% of accumulated mononuclear cells merged with a congenic marker having pathogenic CD4+ T cells, we measured pathogenic CD4+ T cells by counting mononuclear cell numbers in five different spinal sections (see Figure 1A legend), took the average and then calculated the relative number of pathogenic CD4+ T cells, finding a significant accumulation of pathogenic CD4+ T cells in the fifth lumbar cord ( Figure 1A ), a result confirmed by flow cytometry ( Figure 1B ). The accumulation was much greater in the dorsal blood vessels of the fifth spinal cord than in the ventral ones ( Figure 1C ), suggesting dorsal blood vessels of the fifth spinal cord may be the gate to the CNS.
Activation of the IL-6 Amplifier Plays a Role in the Accumulation of Pathogenic CD4+ T Cells in the Fifth Lumbar Cord Because pathogenic CD4+ T cell transfers included both Th1 and Th17 cells (Ogura et al., 2008 ) (data not shown), we next investigated whether cytokines from these pathogenic CD4+ T cells contribute to the CD4+ T cell accumulation in the fifth lumbar cord. For this purpose, we employed IFNg-deficient and IL-17A-deficient mice and immunized them with the MOG peptide plus CFA to obtain pathogenic CD4+ T cells lacking IFNg or IL-17A. We then transferred these pathogenic CD4+ T cells separately into wild-type C57BL/6 mice to investigate T cell migration. Of these, only pathogenic CD4+ T cells from IFNg-deficient mice showed an accumulation in the fifth lumbar cord like that seen in normal pathogenic CD4+ T cells (Figure 2A) , suggesting a role for IL-17A.
We have previously shown that Th17 cells accumulate in joints in a manner dependent on activating the IL-6 amplifier , suggesting that the amplifier might be involved in the above accumulation. Pathogenic CD4+ T cells were intravenously transferred into mutant mice deficient of IL-6 or of either gp130 or STAT3 in their type 1 collagen+ cells and into wild-type C57BL/6 mice. Pathogenic CD4+ T cell accumulation was significantly suppressed in all mutant hosts ( Figure 2B ), suggesting that, indeed, IL-6 amplifier activation was involved. We also found the clinical EAE scores in these mutant mice to be significantly suppressed (data not shown) and the IL-6 concentrations in serum to have decreased ( Figure 2C ). We next identified important type 1 collagen+ cell populations for pathogenic CD4+ T cell accumulation in the fifth lumbar cord, because these cell populations include fibroblasts, endothelial cells, epithelial cells, astrocytes, and activated neuron cells. Pathogenic CD4+ T cells were also transferred into mutant mice with Tie2+ endothelial cells deficient of gp130 and into wild-type C57BL/6 mice. Pathogenic CD4+ T cell accumulation and clinical EAE scores were significantly suppressed in these mutant hosts (Figures S1B and S1C), suggesting the importance of type 1 collagen+ endothelial cells in the accumulation of pathogenic CD4+ T cell in the fifth lumbar cord.
Consistent with these results, STAT3 activation was enhanced in the endothelial cells of dorsal blood vessels in the fifth lumbar cord, but neither in the fourth nor sixth lumbar cords, as determined by STAT3 phosphorylation levels ( Figure 2D ). These results indicate IL-6 amplifier activation in endothelial cells has a significant role in pathogenic CD4+ T cell accumulation in the fifth lumbar cord during EAE development.
CCL20 Expression Contributes to the Accumulation of Pathogenic CD4+ T Cells in the Fifth Lumbar Cord
We next attempted to identify a critical target molecule for STAT3 and NFkB activation in type 1 collagen+ endothelial cells during IL-6 amplifier activation. We considered chemokines like CCL20, because they are synergistically expressed via STAT3 and NFkB in type 1 collagen+ cells, are critical for Th17 cell accumulation in an arthritis model , and because pathogenic CD4+ T cells from mice deficient of CCR6, a CCL20 receptor, showed minimal accumulation in the fifth lumbar cord ( Figure S2A ). We found that CCL20 expression in the dorsal blood vessels of the fifth lumbar cord increased even in the absence of pathogenic CD4+ T cell transfer ( Figure 3A) , with no such concomitant effect in vessels of the thoracic and cervical cords ( Figure S2B ). Interestingly, CCL20 expression eventually reached other regions like the anterior lumbar cords after pathogenic CD4+ T cell transfer ( Figure S2C , right), suggesting that the bloodbrain barrier is compromised broad regions after pathogenic T cell accumulation in the CNS. Furthermore, along with CCL20, chemokines such as CCL2, CCL3, CCL9, CCL21, CCL24, CX3CL1, CXCL1, CXCL2, CXCL9, and CXCL11 increased in the dorsal blood vessels of the fifth lumbar cord compared to the first lumbar cord ( Figures 3A and 3B ), while anti-CCL20 antibody treatment in vivo significantly suppressed pathogenic CD4+ T cell accumulation and the development of EAE ( Figures 3C-3E) .
We next investigated for correlations between CCL20 expression and IL-6 amplifier activation in the fifth lumbar cord. Again, mutant mice deficient of IL-6 or of either gp130 or STAT3 in their type 1 collagen+ cells were employed. CCL20 messenger RNA (mRNA) expressions in the dorsal blood vessels of the fifth lumbar cord was less in all three mutant recipients than in wild-types ( Figure 3F ). Together with the importance of IL-17A and CCR6 expression in pathogenic CD4+ T cells, these results suggest that CCL20 expression, which is known to be regulated by IL-6 amplifier activation, at least in joints, plays a similar role in pathogenic CD4+ T cell accumulation in the fifth lumbar cord and that this leads to EAE development. 
Sensory Nerve Activation via Soleus Muscles Is Critical for CCL20 Expression in the Fifth Lumbar Cord and the Ensuing Pathogenic CD4+ T Cell Accumulation
We then considered how the IL-6 amplifier in dorsal blood vessels of the fifth lumbar cord is activated to express CCL20 prior to pathogenic CD4+ T cell transfer. We focused on the activation of soleus muscle-mediated sensory nerves, because their dorsal root ganglia locate near the fifth lumbar (Ohira et al., 2004) . We hypothesized that frequent stimulation of the soleus muscles in response to a gravitational stimulus could induce activation of the IL-6 amplifier via their sensory nerves, which in turn would directly or indirectly induce high CCL20 expression in the blood vessels of the fifth lumbar cord. For this, we employed a tail suspension model, which is a widely accepted National Aeronautics and Space Administration ground-based model for studying disuse-atrophy in rodents to eliminate any response by the hind legs to the stimulus (Canu and Garnier, 2009; De-Doncker et al., 2005; Kawano et al., 2007; Nakao et al., 2009) . Tail suspensions significantly decreased CCL20 expression in dorsal blood vessels of the fifth lumbar cord (see the left two columns in Figure 4A ). Consistent with this, tail suspensions also significantly suppressed pathogenic CD4+ T cell accumulation in the fifth lumbar cord ( Figure 4B ), while pathogenic CD4+ T cell accumulation and CCL20 expression in cervical cord blood vessels increased, especially in the posterior side ( Figure 4B and Figure S3A ). Moreover, c-fos expression levels decreased in fifth dorsal root ganglia ( Figure 4C ), but increased in the dorsal root ganglia of the cervical spine after tail suspension ( Figure S3B ). Finally, EAE development was significantly inhibited when the tail was suspended ( Figure 4D ).
In normal mice without pathogenic CD4+ T cell transfer, NFkB activation, which like STAT3 activation is also critical for IL-6 amplifier activation, was enhanced in the blood vessels of the fifth lumbar cord, but not in those of the first lumbar or cervical cords ( Figure 4E ). Tail-suspended mice, however, responded differently, as NFkB activation was enhanced in vessels of the cervical cord, but not those of the first or fifth lumbar cords (Figure 4E) . These data strongly suggest sensory nerve activation by the soleus muscles plays a role in CCL20 expression in the dorsal vessels of the fifth lumbar cord prior to the development of autoimmune diseases that occur from an accumulation of pathogenic CD4+ T cells. To confirm this, we stimulated soleus muscles directly by using an electronic stimulator while mice were suspended from their tails. Electronic stimulations in the soleus muscles increased CCL20 expressions in the dorsal blood vessels in a manner dependent on stimulus duration (see the right four columns in Figure 4A ). These stimulations also increased the number of pathogenic CD4+ T cells in the fifth lumbar cord ( Figure 4B ) and c-fos expression in the fifth lumbar dorsal root ganglia ( Figure 4C ). All these results are consistent with regional neural activations via soleus muscle-mediated sensory nerve activation creating gates for pathogenic CD4+ T cell accumulation into the CNS.
For further validation of our tail suspension model, five additional experiments were done. In the first, electrically stimulating the quadriceps, whose afferent nerves come from the third lumbar dorsal root ganglia, and the epitrochlearis/triceps brachii, whose afferent nerves come from between the fifth cervical and fifth thoracic dorsal root ganglia, caused CCL20 expression to increase in the third lumbar vessels and between the fifth cervical and fifth thoracic vessels, respectively ( Figure S3C ). Similarly, these stimulations increased cfos expression ( Figure S3D ). We next employed a deafferentation method where afferent fibers of the fifth lumbar dorsal root ganglia were resected to reduce the soleus muscle response against gravity while only making minimal changes to body balance (Kawano et al., 2007) . We found CCL20 expression in the fifth lumbar vessels decreased just like that in the tail suspension model, while CCL20 expression in the first lumbar vessels were unchanged ( Figure S3E ). Furthermore, cfos expression decreased in dorsal root ganglia of the fifth lumbar cords ( Figure S3F ). We employed tail suspensions plus a casting, as this combination is reported to increase dorsal root ganglion activation , finding the increase in CCL20 expression in the fifth lumbar vessels was even greater than tail suspension alone ( Figure S3G ). Finally, we investigated blood flow speed in blood vessels of the fifth lumbar dorsal region, bottoms of the forefeet, palms, femoral vessels, brain surface vessels, portal vein, and intestinal microvessels in normal and tail suspended mice. In all cases, speeds were comparable for all investigated regions between the two mouse types except for the fifth lumbar region ( Figure S3H ). These results demonstrate the viability of our tail suspension model and indicate that regional neural activations create gates for pathogenic CD4+ T cell entry into the CNS by increasing CCL20 expression.
Soleus Muscle-Mediated Sensory Nerve Activation at Least Partially Enhances CCL20 Expression in the Fifth Lumbar Cord via Sympathetic Neurons Finally, we considered how sensory nerve activations from soleus muscles change the state of dorsal vessels of the fifth lumbar cord to cause an accumulation of pathogenic CD4+ T cells.
Continuing the blood flow speed experiments described above, we found electrically stimulating soleus muscles can change fifth lumbar blood flow speed ( Figure 5A ). Additionally, treatment with the norepinephrine antagonist atenolol significantly suppressed CCL20 mRNA expression, NFkB activation, and pathogenic CD4+ T cell accumulation around these vessels and abrogated EAE development (Figures 5B-5F ). Similar results were obtained (F) CCL20 mRNA expression in the dorsal blood vessels of the fifth lumbar cord, in wild-type C57BL/6 and mutant mice deficient of IL-6 or of gp130 or STAT3 in their type 1 collagen+ cells. CCL20 expression in the fifth lumber cord decreased in all mutant mice comparing to wild-type ones. Error bars represent the mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.005 (A and C-F). Error bars represent the mean ± SD, *p < 0.05, **p < 0.01 (B). See also Figure S2 .
using another norepinephrine antagonist, prazosin ( Figure S4) . Furthermore, about 15% of sympathetic nerves in fifth lumbar spine ganglia expressed c-fos molecules, while first lumbar spine ganglia did not, which is consistent with CCL20 expression in their dorsal vessels ( Figure 5G ). Consistent with these in vivo results, norepinephrine enhanced IL-6 amplifier activation based on IL-6 or CCL20 expression levels in vitro ( Figures 5H and 5I ). Taken together, these results indicate that sympathetic nerve activation induced by soleus muscles is at least partially involved in the enhanced expression of chemokines like CCL20 in dorsal blood vessels, and that this leads to an accumulation of pathogenic CD4+ T cells in the fifth lumbar cord ( Figure 5J ). All these results demonstrate that regional neural activations via the soleus muscle-mediated sensory nerve enable pathogenic CD4+ T cell entry into the CNS from adjacent blood vessels.
DISCUSSION
Although it is known that autoimmune diseases can correlate with neurological states like stress, how neural signals are physically transformed into an immune response in the CNS is poorly understood. In the current study, we describe how regional neural activations can create gates in specific blood vessels that allow for immune cell entry into the CNS. We employed sensory neural activations of the soleus muscles, finding sympathetic nerve activations here lead to excess CCL20 expression in the fifth lumbar cord in a manner dependent on the activation of the IL-6 amplifier. This in turn leads to the activation of NFkB and STAT3 in type 1 collagen+ endothelial cells. Therefore, neuroimmune interactions induce regional alterations in blood vessels and venules such that immune cells can enter the CNS. When pathogenic helper T cells are in the blood stream, these neuroimmune interactions risk the development of autoimmune disease. IL-6 amplifier activation has been shown to be critical for the development of autoimmune diseases like EAE and rheumatoid arthritis (Hirano, 2010; Ogura et al., 2008) . We recently proposed a mechanism that depends on local IL-6-amplifier activation to explain the development of MHC class II-associated diseases as a four-step model for autoimmune diseases. This model shows four local events that must occur (E) NFkB activation monitored by luciferase activity in the dorsal blood vessels of the first lumbar cord (L1), fifth lumbar cord (L5), and spinal cords in the cervical spines (C1-C7) of C57BL/6 mice transduced with a NFkB reporter with or without TS. NFkB activation in the fifth lumber cord increased comparing to other lumber cords without tail suspension, while that in the cervical cords increased comparing to other lumber cords after tail suspension. Dorsal blood vessels were isolated under a stereoscopic microscope. Error bars represent the mean ± SEM, *p < 0.05, **p < 0.01 (A, B, D, and E). Error bars represent the mean ± SD, **p < 0.01 (C). See also Figure S3 .
prior to chronic activation of the IL-6 amplifier and subsequent chronic inflammation in the affected tissue: (1) activation of CD4+ T cells regardless of the antigen-specificity, (2) triggering factors for local accumulation of CD4+ T cells, (3) transient activation of the IL-6 amplifier in local tissues by cytokines from the CD4+ T cells, and (4) increased sensitivity to the cytokines in these local tissues (Murakami and Hirano, 2011) . Furthermore, it is likely that each step interacts with the others, the degree of which varies with the pathogenesis of the disease. Our current results lead us to propose that neural activation may contribute to steps 2 or 4. Sensory neural activation of the soleus muscles activated sympathetic neurons. This was followed by CCL20 expression via IL-6 amplifier activation. That sympathetic nerves are involved is consistent with other reports in which EAE was induced by systemic immunization in the presence or absence of norepinephrine antagonists (Brosnan et al., 1985; Dimitrijevi c et al., 2007) . We suspect increased blood flow speed in the fifth (G-I) IL-6 amplifier activation was enhanced in the presence of norepinephrine. BC1 cells stimulated with human IL-6 plus soluble IL-6 receptor and/or IL-17A for 48 hr in the absence or presence of norepinephrine (G, 10-300 mM; H, 100 mM). Culture supernatants were collected and assessed using an ELISA specific for mouse IL-6 (H) and CCL20 (I). IL-6 and CCL20 concentrations increased in the presence of norepinephrine in each condition. (J) Schematic figure of neural activation-induced pathogenic T cell accumulation in the CNS. Neural activation-mediated IL-6 amplifier enhancement in endothelial cells of dorsal blood vessels in the fifth lumbar cord induces CCL20 followed by the accumulation of pathogenic Th17 cells, a critical event for the development of EAE. Error bars represent the mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.005 (A-F). Error bars represent the mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.005 (G-I). See also Figure S4 . lumbar cord is a direct or indirect effect of the exercise pressor reflex, which is an example of sensory neuron stimulation that leads to sympathetic neuron activation (Kaufman and Hayes, 2002; Smith et al., 2006) . Activation of this reflex changes blood pressure or blood flow via alterations in the blood vessel, particularly those in muscle (Kaufman and Hayes, 2002; Smith et al., 2006) . However, it is still an open question on how sensory neurons via the soleus connect to sympathetic neurons and the sympathetic ganglion. We suspect this connection occurs at the dorsal root ganglia of the fifth lumbar cord, since even though sympathetic axons exist in normal dorsal root ganglia they increase in number following a sensory neuron injury (Xie et al., 2010) .
Unlike mice, patients suffering from MS do not always display symptoms in their lower body. Instead, MS symptoms are generally isolated in the upper body, particularly the thoracic cord and cerebrum. This difference might be due to different sites for the pathogenic CD4+ T cell accumulation that follows local inflammation. Because different regional neural activation-mediated CCL20 expression were induced by stimulating several muscles such as the soleus muscles, the quadriceps, and epitrochlearis/ triceps brachii ( Figure 4A and Figures S3C and S3D) , we believe that excess sensory stimulations in other regions like the hands, fingers, and optic nerves, and even less visceral locations like chronic mental stress may affect MS symptoms by promoting excess neural activations and IL-6 amplifier activation in vessels of the thoracic cord and/or cerebrum. Such a theory could also help explain the effects of acupuncture, which involves directly stimulating peripheral nerves to change body homeostasis (Longhurst, 2010) . We therefore hypothesize that acupuncture effects may arise by changing the blood vessel status of the target organ.
In the rat transfer models, pathogenic T cells migrate to the spleen prior to entering the CNS (Matsumoto et al., 1988; Panitch, 1980 ). That we found pathogenic CD4+ T cells negligibly accumulate in the fifth lumbar cord by day 4 is consistent with this. However, we also found that the fifth lumbar cord shows chemokine expression even in the steady state ( Figures 3A  and 3B ). Such an observation suggests that the transferred pathogenic CD4+ T cells need not wait until day 4, as they can instead enter the spinal cord using this axis directly. One reason we did not find earlier T cell accumulation may be that the pathogenic CD4+ T cells express relatively low levels of CCR6 after in vitro culture. That would explain why CCR6 expression levels increased following pathogenic CD4+ T cell division in the superficial lymph nodes, aortal lymph nodes, mescenteric lymph nodes, and spleens on day 4 after the transfer ( Figure S5 ) and that deficient CCR6 in pathogenic CD4+ T cells suppressed early T cell entry into the CNS ( Figure S2A ). Additionally, CCL20 or adrenergic inhibition reduced EAE development, particularly for the first 5 days after pathogenic CD4+ T cell transfer ( Figures  3D and 5E ), while anti-CCL20 or an adrenergic receptor inhibitor from day 8 after the pathogenic CD4+ T cell transfer upon indications of slight tail polarization ( Figures 3E and 5F ). Theses results suggest that both blockades have partial therapeutic effects for multiple sclerosis.
It has been observed that the expression of chemokines like CCL20 in the dorsal vessels of the fifth lumbar cord in response to soleus muscle stimulation can facilitate immunity against pathogenic invasions or latent infectious states in the CNS (McGavern and Kang, 2011; Salinas et al., 2010) . Consistent with this, we found the expression of all observed chemokines increased there. This increase could also signal the recruitment of other cell populations, including nonimmune cells as well as other neural precursor cells including microglia ones. Therefore, regional neural activations may maintain homeostasis of the CNS environment by regulating the entry of various cell types from the blood. These phenomena then may suggest the importance of the IL-6 amplifier, a synergistic signal between NFkB and STAT3, for the accumulation of various cell types including pathogenic T cells by creating a gateway to CNS that depends on various sets of chemokine expressions.
To summarize, we describe an entry site at the dorsal blood vessels of the fifth lumbar cord for blood cells including pathogenic CD4+ T cells into the CNS. Mechanistic experiments demonstrated that CCL20, which we found to be positively regulated by sensory nerve activation via antigravity soleus muscles, plays a role in this accumulation, and that its expression risks the development of autoimmune diseases when pathogenic CD4+ T cells are present in the blood stream. More importantly, sensory nerve activation enhances CCL20 expression in these dorsal blood vessels via the activation of sympathetic neurons, meaning neural activation can be transformed into an inflammatory signal that leads to autoimmune disease. The location of this neuroinflammatory transformation may prove a valuable therapeutic target for various neuroimmune diseases including autoimmune and inflammatory diseases and is therefore worthy of more study.
EXPERIMENTAL PROCEDURES
Mouse Strains C57BL/6 mice were purchased from Japan SLC. IL-6-deficient mice were provided by Dr. M. Kopf (Max Planck Institute of Immunobiology, Germany) and backcrossed with C57BL/6 mice more than ten times. Type I collagenCre mice were provided by Dr. G. Karsenty (Baylor College of Medicine, Houston, TX) and crossed with STAT3 flox/flox mice (provided by Dr. S. Akira, Osaka University, Japan) (Takeda et al., 1998) and gp130 flox/flox mice (Betz et al., 1998) . Tie2-Cre mice were provided by Dr. H. Kawamoto (RIKEN Research Center for Allergy and Immunology, Yokohama, Japan). IL-17A-deficient (Iwakura and Ishigame, 2006) , NFkB reporter (Sadikot and Blackwell, 2008) , CCR6-deficient (Varona et al., 2001) , and IFNg-deficient (Ueda et al., 2006) mice in a C57BL/6 background were also used. All mice were maintained under specific pathogen-free conditions according to the protocols of the Osaka University Medical School. All animal experiments were performed following the guidelines of the Institutional Animal Care and Use Committees of the Graduate School of Frontier Bioscience and Graduate School of Medicine, Osaka University.
Passive Transfer of Pathogenic CD4+ T Cells to Induce EAE EAE induction was performed as described previously (Ogura et al., 2008) . In brief, C57BL/6 mice and IL-17A-deficient, IFNg-deficient mice were injected with a MOG (35-55) peptide (synthesized by Sigma) in complete Freund's adjuvant (Sigma-Aldrich, Tokyo) at the base of the tail on day 0 followed by intravenous injection of pertussis toxin (Sigma-Aldrich, Tokyo) on days 0, 2, and 7. On day 10, CD4 + T cells from the resulting mice were sorted with anti-CD4 microbeads (Milteny, Tokyo). The resulting CD4 + T cell-enriched population (4 3 10 6 cells) was cocultured with rIL-23 (10 ng/ml; R&D, Minneapolis) in the presence of MOG peptide-pulsed bone marrow-derived dendritic cells (5 3 10 5 ) for 2 days. Cells (1.5 3 10 7 ) were then injected intravenously into wild-type or mutant mice. Clinical scores were measured as described previously (Ogura et al., 2008) .
Mononuclear Cell Isolation from Spinal Cords
Mononuclear cells from spinal cords were isolated after cardiac perfusion with PBS as described previously (Sawa et al., 2009 ).
Frozen Section Preparations and Histological Analysis
Spines were harvested and fixed in 4% paraformaldehyde for 12 hr and then displaced with 10% sucrose solution for 12 hr, 20% sucrose solution for 12 hr, and finally 30% sucrose solution for 12 hr (total 48 hr). The resulting spines were embedded in SCEM compound (SECTION-LAB, Japan). The cut surface was covered with an adhesive film (Cryofilm type IIC9, SECTION-LAB, Japan) and frozen sections (10 mm) were prepared with a macrotome (CM3600XP Leica Microsystems, Germany) according to a method described previously (Kawamoto, 2003) . The resulting sections were stained with hematoxylin/eosin and analyzed with a BZ-9000 microscope (KEYENCE).
Intracellular Cytokine Staining
The number of Th17 cells in vivo was determined as previously described (Nishihara et al., 2007) . In brief, T cells from spinal cords were stimulated with MOG peptide presented on LPS-stimulated bone marrow-derived dendritic cells in the presence of GolgiPlug (BD Biosciences, Tokyo) for 6 hr. Intracellular IL-17A and IFN-g were labeled with anti-IL-17A and anti-IFN-g antibodies after surface staining, fixation, and permeabilization.
Antibodies and Reagents
The following antibodies were used for flow cytometry analysis: APC-conjugated anti-IFN-g (eBioscience, San Diego) and control IgG1k (eBioscience, San Diego); FITC-conjugated anti-CD8 (eBioscience, San Diego), anti-CD19 (eBioscience, San Diego), anti-B220 (BD PharMingen, Tokyo), anti-NK1.1 (eBioscience, San Diego), and anti-I-A/I-E (BioLegend, Tokyo); PE-conjugated anti-IL-17A (eBioscience, San Diego), control IgG2a (eBioscience, San Diego), and anti-I-A/I-E (BioLegend, Tokyo); PE-Cy5-conjugated anti-CD4 (BioLegend, Tokyo); PE-Cy7-conjugated anti-CD4 (BioLegend, Tokyo); Pacific Blue-conjugated anti-CD44 (eBioscience, San Diego) and Streptavidin (Invitrogen, Tokyo); and Biotin-conjugated anti-CD90.2 (eBioscience, San Diego). The following antibodies were used for immunohistochemistry: antiphospho-STAT3 (Tyr705, D3A7) (Cell signaling), anti-tyrosine hydroxylase (Abcam, Tokyo), anti-cFos (Sigma, Tokyo), and control rabbit IgG (DA1E) (Cell Signaling, Tokyo); and Alexa Fluor 488 goat anti-rabbit IgG (H + L) and Alexa 647 goat anti-chicken IgG (Invitrogen, Tokyo). The following antibodies were used for in vivo neutralization: purified anti-mouse CCL20 mAb (R&D, Minneapolis). Atenolol and prazosin were purchased from Sigma-Aldrich, Tokyo. The VECTASTAIN Elite ABC Rabbit IgG Kit and the DAB Peroxidase Substrate kit were purchased from Vector Laboratories, Burlingame.
ELISA IL-6 and IL-17A levels in serum or cell cultures supernatant were determined with ELISA kits (BD PharMingen, Tokyo; eBioscience, San Diego; or R&D, Minneapolis). CCL20 levels in cell cultures supernatant were determined using ELISA kits (R&D, Minneapolis).
Flow Cytometry
For cell surface labeling, 10 6 cells were incubated with fluorescence-conjugated antibodies for 30 min on ice. The cells were then analyzed with cyan flow cytometers (Beckman Coulter, Tokyo). The collected data were analyzed with Summit software (Beckman Coulter, Tokyo) and/or Flowjo software (Tree Star, Ashland).
Laser Microdissection
Approximately 100 frozen sections (15 mm) were fixed with acetic acid/ethyl alcohol (1:19) for 15 min followed by PBS washing for 10 min. Tissues around the dorsal blood vessels were collected by a laser microdissection device, DM6000B (Leica, Tokyo), and prepared for total RNA measurements by the GenElute Mammalian Total RNA kit (Sigma-Aldrich, Tokyo) and DNase I (Sigma-Aldrich, Tokyo).
Real-Time PCRs
A GeneAmp 5700 sequence detection system (ABI, Warrington) and SYBER green PCR Master Mix (Sigma-Aldrich, Tokyo) were used to quantify CCL20 mRNA and HPRT mRNA levels. The PCR primer pairs used for real-time PCRs were as follows: mouse HPRT primers, 5 0 -GATTAGCGATGATGAACCA GGTT-3 0 and 5 0 -CCTCCCATCTCCTTCATGACA-3 0 ; mouse CCL20 primers, 
Hindlimb Suspension
Hindlimb suspension was performed as described previously (Kawano et al., 2007; Ohira et al., 2002) . In brief, strips of sticky tape (about 5 mm wide and 3 cm long) with good cushion were placed longitudinally on the dorsal and ventral sides of the midtail of the hindlimb-unloaded mouse. These strips were further surrounded cross-sectionally by another strip. Strips were adhesed loosely so as to keep the blood flow intact. A string was inserted through the gap between the tail and tape and fastened to the roof of the cage at a height that allowed the forelimbs to support the body weight and prevent the hindlimbs from touching any part of the cage. A mouse could reach food and water freely by using its forelimbs. The attachment to the tail was changed each week so as not to inhibit tail growth and blood flow.
Electro Stimulations
In some experiments, hindlimb suspended mice were electrostimulated for 12 hr through the soleus muscle with electrical stimulators (Nippon Koden, Tokyo and Unique Medical, Osaka) at 0.1 mA and 1-8 ms random intervals. Electrostimulations were done for 1 day when investigating pathogenic CD4+ T cell migration and two days when measuring CCL20 mRNA expression.
Anti-CCL20 Antibody, Atenolol Treatment, and Prazosin Treatment Anti-CCL20 antibody (200 mg/mouse) or atenolol (500 mg/mouse) was interperitoneally injected into C57BL/6 mice (6-8 weeks old) for 5 days in which pathogenic CD4+ T cells were transferred. Atenolol (500 mg/mouse) or prazosin (500 mg/mouse) was injected into wild-type C57BL/6 mice (6-8 weeks old) for 5 days without the pathogenic CD4+ T cell transfer.
Luciferase Assay
Blood vessels from the dorsal side of the fifth lumbar cord or first lumbar cord were harvested. Proteins were collected using a Luciferase Reporter Assay kit (Promega, Tokyo) and total protein amount was adjusted. Luciferase activities were measured by a Luciferase detection device (Promega, Tokyo).
Blood Flow Analysis
Blood flow volume was measured in blood vessels from the dorsal side of the fifth lumbar cord in C57BL/6 mice (6-8 weeks old) in the presence or absence of tail-suspensions and/or electrostimulations with Omegazone OZ-1 (Omega wave, Tokyo).
Statistical Analysis
Student's t tests (two-tailed) and ANOVA tests were used for the statistical analysis of differences between two groups and that of differences between more than two groups, respectively.
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